Vidac Pharma

Indonesia
Sumbul, North Sumatra, Indonesia, 9777510

Company profile

Vidac Pharma company profile

Vidac is a clinical stage innovative biopharmaceutical company dedicated to discovering and developing first-in-class medicines to help people suffering from a range of oncology and dermatology ailments. We at Vidac are passionate about transforming breakthrough science into innovative therapies to address major unmet medical needs. Our breakthrough technology targets the VDAC/HK2 system that is unique to malignant cells. Modulating this target leads to selective apoptosis of cancer cells without affecting the surrounding healthy tissue, thus holds the promise of delivering first-in-class drugs that are both efficacious and well tolerated by patients.

Business identity

Contact email
[email protected]
Phone number
+97225952090
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2011-01-01, Year

Headquarters

Postal code
9777510
Country code
ID
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$9M
Last funding
Series A / $9M / 2016-06-29
Last equity funding
Series A / $9M
Investors
1
Lead investors
1
Founders
1
Articles
45

Founders and investors

Founders

Max Herzberg

Lead investors

Israel Biotech Fund

Investors

Israel Biotech Fund